Paradigm Biopharmaceuticals Ltd.ASX: PAR

Application for quotation of securities - PAR

Jul 30, 2026 at 2:56 AM EDT · Issued by Paradigm Biopharmaceuticals Ltd. via ASX

Filed with ASX · Jul 30, 2026 at 2:56 AM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-par-4

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name PARADIGM BIOPHARMACEUTICALS LIMITED.. Announcement Type New announcement Date of this announcement Thursday July 30, 2026 The +securities to...

View Attachment

6ix hasn’t read this filing yet.

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

June 2026 Quarterly Activities Report & Appendix 4CJul 29
Paradigm Receives $5.75m R&D Tax Incentive RefundJul 21
Drawdown of Tranche 4 under the Convertible Note FacilityJul 12
PAR Completes Enrolment in Pivotal Phase 3Jun 14
Results of Share Purchase PlanMay 31

Later from Paradigm Biopharmaceuticals

80% Safety Review Complete, September IA on TrackAug 12
Appendix 4G and Corporate Governance StatementAug 27
Appendix 4E and 2026 Annual ReportAug 27
Melbourne Investor LunchSep 2
Notification regarding unquoted securities - PARSep 10

All Paradigm Biopharmaceuticals news releases

Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.

Follow Paradigm Biopharmaceuticals